PT  - JOURNAL ARTICLE
AU  - Avaneesh Singh
AU  - Manish Kumar Bajpai
AU  - Shyam Lal Gupta
TI  - A Time-dependent mathematical model for COVID-19 transmission dynamics and analysis of critical and hospitalized cases with bed requirements
AID  - 10.1101/2020.10.28.20221721
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.28.20221721
4099  - http://medrxiv.org/content/early/2020/11/03/2020.10.28.20221721.short
4100  - http://medrxiv.org/content/early/2020/11/03/2020.10.28.20221721.full
AB  - A time-dependent SEAIHCRD model is the extension of the SEIR model, which includes some new compartment that is asymptomatic infectious people, hospitalized people, critical people, and dead compartments. In this article, we analyzed six countries, namely the United States, Brazil, India, South Africa, Russia, and Mexico. A time-dependent SEAIHCRD model calculates the magnitude of peaks for exposed people, asymptomatic infectious people, symptomatic infectious people, hospitalized people, the number of people admitted to ICUs, and the number of COVID-19 deaths over time. It also computes the spread scenario and endpoints of disease. The proposed model also involves asymptomatic infectious individuals. To estimate the various parameters, we first collect the data and fit that using the Lavenberg-Marquardt model for death cases. Then we calculate infection rate, recovery rate, case fatality rate, and the basic reproduction number over time. We calculate two types of case fatality rates: one is the daily case fatality rate, and the other is the total case fatality rate. The proposed model includes the social distance parameter, various age classes, hospital beds for severe cases, and ICU beds or ventilators for critical cases. This model will be useful to determine various essential parameters such as daily hospitalization rate, daily death rates, including the requirement of normal and ICU beds during peak days of infection.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialFor this research, no need of clinical trial.Funding StatementThe work has been supported by a grant received from the Ministry of Education, Government of India under the Scheme for the Promotion of Academic and Research Collaboration (SPARC) (ID: SPARC/2019/1396).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approve all policiesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used public available data which are taken from trusted government agencies https://www.who.int/ https://www.mohfw.gov.in/